Strumento inattivo

Altre lingue SofWave Medical Ltd. TEL AVIV STOCK EXCHANGE

Azioni

SOFW

IL0011754392

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference	28/03
Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	06/03
SofWave Medical : Presentation- Investor Meeting-March 2024	06/03
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting	04/03
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	28/02
Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer	12/02
SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer	12/02
Sofwave Medical Receives 510(k) Marketing Clearance for Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology	03/01
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	03/01
Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	26/12
Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime	20/11
Sofwave Medical Reports Third Quarter 2023 Financial Results and Business Highlights	08/11
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Treatment of Acne Scars	30/08/23
Sofwave Medical Announces FDA Clearance of SUPERB? Technology For Treatment of Acne Scars	30/08/23
Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights	08/08/23
SofWave Medical : Presentation -August 2023	08/08/23
SofWave Medical Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue SofWave Medical Ltd. TEL AVIV STOCK EXCHANGE

Azioni

SOFW

IL0011754392

Altre lingue

Filtri